This is a preprint.
Mechanism of Tethered Agonist Binding to an Adhesion G-Protein-Coupled Receptor
- PMID: 40799601
- PMCID: PMC12340805
- DOI: 10.1101/2025.08.04.668378
Mechanism of Tethered Agonist Binding to an Adhesion G-Protein-Coupled Receptor
Abstract
Adhesion GPCRs (ADGRs) contain a GPCR autoproteolysis-inducing (GAIN) domain that is proximal to the receptor N-terminus and undergoes autoproteolysis at a highly conserved GPCR proteolysis (GPS) site to generate the N-terminal fragment (NTF) and transmembrane C-terminal fragment (CTF). Dissociation of NTF reveals a peptide tethered agonist (TA) which is responsible for the activation of the ADGRs. The NTF-bound ADGRs contain the encrypted TA that assumes a β-strand configuration within the GAIN domain, which is markedly different from a U-shaped α-helical configuration of TA in the active cryo-EM structures of ADGRs. However, how the TA dramatically changes its configuration and binds to the ADGR CTF remains unknown. In this study, we have performed all-atom enhanced sampling simulations using a novel Peptide-Gaussian accelerated Molecular Dynamics (Pep-GaMD) method on TA binding to the ADGRD1. The Pep-GaMD simulations captured spontaneous binding of the TA into orthosteric pocket of the ADGRD1 and its large conformational transition from the extended β strand to the U-shaped α helical configuration. We were able to identify important low-energy conformations of the TA in the binding pathway, as well as different active and inactive states of ADGRD1, in the presence and absence of the Gs protein. Therefore, our Pep-GaMD simulations have revealed dynamic mechanism of the TA binding to an ADGR, which will facilitate rational design of peptide regulators of ADGRs.
Keywords: Adhesion G-protein-coupled receptors; Peptide-Gaussian accelerated Molecular Dynamics; binding; enhanced sampling; tethered agonist.
Conflict of interest statement
Notes The authors declare no competing financial interest.
Figures





Similar articles
-
Mechanisms of Peptide Agonist Dissociation and Deactivation of Adhesion G-Protein-Coupled Receptors.Biochemistry. 2025 Feb 18;64(4):871-878. doi: 10.1021/acs.biochem.4c00531. Epub 2025 Feb 4. Biochemistry. 2025. PMID: 39902762 Free PMC article.
-
Mechanisms of peptide agonist dissociation and deactivation of adhesion G-protein-coupled receptors.bioRxiv [Preprint]. 2024 Sep 14:2024.09.07.611823. doi: 10.1101/2024.09.07.611823. bioRxiv. 2024. Update in: Biochemistry. 2025 Feb 18;64(4):871-878. doi: 10.1021/acs.biochem.4c00531. PMID: 39314495 Free PMC article. Updated. Preprint.
-
Disentangling autoproteolytic cleavage from tethered agonist-dependent activation of the adhesion receptor ADGRL3.J Biol Chem. 2022 Dec;298(12):102594. doi: 10.1016/j.jbc.2022.102594. Epub 2022 Oct 14. J Biol Chem. 2022. PMID: 36244455 Free PMC article.
-
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3. Cochrane Database Syst Rev. 2007. PMID: 17253483 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
-
- Thathiah A.; De Strooper B. The role of G protein-coupled receptors in the pathology of Alzheimer’s disease. Nature Reviews Neuroscience 2011, 12 (2), 73–87. - PubMed
-
- Heng B. C.; Aubel D.; Fussenegger M. An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnology advances 2013, 31 (8), 1676–1694. - PubMed
-
- Wang D. The essential role of G protein-coupled receptor (GPCR) signaling in regulating T cell immunity. Immunopharmacology and immunotoxicology 2018, 40 (3), 187–192. - PubMed
-
- Gutierrez A. N.; McDonald P. H. GPCRs: Emerging anti-cancer drug targets. Cellular signalling 2018, 41, 65–74. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous